Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Full-Year Revenue Guidance — Lower end by Quarter
Full-Year Revenue Guidance — Lower end ($M) ($M)
Pfizer Full-Year Revenue Guidance — Lower end: $60,500M in Q2 2026, down 0.8% from a year earlier.
Where the Q2 2026 figure comes from
“|| Revenues ($ in billions) Midpoint | $59.5 to $62.5 $61.0 | +$1.5 | -$1.0 | - | $60.5 to $62.5 $61.5”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Management full-year guidance ranges as affirmed or updated in each quarterly Form 8-K earnings release ($B converted to $M).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up full-Year Revenue Guidance — Lower end
- Full-Year Revenue Guidance — Upper end ($M)62,500 · Q2 2026
- Full-Year Adjusted SI&A Expense Guidance — Lower end ($M)12,500 · Q2 2026
- Full-Year Adjusted SI&A Expense Guidance — Upper end ($M)13,500 · Q2 2026
- Full-Year Adjusted R&D Expense Guidance — Lower end ($M)10,500 · Q2 2026
- Full-Year Adjusted R&D Expense Guidance — Upper end ($M)11,500 · Q2 2026
- Full-Year Adjusted Diluted EPS Guidance — Lower end ($/share)2.80 · Q2 2026
- Full-Year Adjusted Diluted EPS Guidance — Upper end ($/share)3 · Q2 2026
- Full-Year Effective Adjusted Tax Rate Guidance (~%)15.0% · Q2 2026
Cite this data
StockData. (2026). Pfizer Full-Year Revenue Guidance — Lower end ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/guid-rev-low
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.